Clinical Trial Update: MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating magnesium to prevent atrial arrhythmias after cardiac surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Valvular Heart Disease

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: University of British Columbia | Conditions: Coronary Artery Disease, Valvular Heart Disease | Phase 3 | Status: TERMINATED